Notably, patients with high TXNIP expression had activation of pathways involved in proteostasis (mTOR and UPR), MM survival (IL6, insulin, and NOTCH1 signaling), and energy control (amino acid metabolism and lipid metabolism), as shown in Fig. 4J. This evidence concerns the gene IL6 and Miyoshi myopathy.